Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Meda has entered into a five year collaboration agreement with Omega Pharma for SB12 in France, Italy, Belgium and Greece.
Subscribe to our email newsletter
SB12 is an oral care agent for bad breath. Meda has established SB12 in the Nordic region.
In 2012, Meda intends to launch SB12 in about ten markets across Europe under its own management, the company said.